• Genomics
  • Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy," Pharmacogenetics and Genomics , vol. 17, no. 9, pp. 755-764, 2007. (hindawi.com)
  • adults
  • See 'Overview of medical care in adults with diabetes mellitus', section on 'Dyslipidemia' . (uptodate.com)
  • Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group," Clinical Infectious Diseases , vol. 37, no. 5, pp. 613-627, 2003. (hindawi.com)
  • clinical
  • Comprising contributions from leading lipidologists from around the world, this book presents the latest and most comprehensive knowledge on the different options for combination therapy of dyslipidemia and includes discussion of future therapies that are currently in late stages of clinical evaluation. (springer.com)
  • adolescents
  • 1 In children and adolescents, dyslipidemia is also defined as having a TC, LDL-c, and/or TAG level higher than the 95th percentile or an HDL-c level lower than the 10th percentile for age and gender. (scielo.br)
  • The majority of the cases of dyslipidemia in children and adolescents are related to obesity, 13-17 high waist-to-hip ratio, family history of dyslipidemia, 17 and lifestyle factors such as high consumption of unhealthy dietary patterns, 18-20 meals rich in cholesterol and energy 21 and low intake of unsaturated fatty acids. (scielo.br)
  • Behavioral changes are the first line of treatment for dyslipidemia in adolescents, but outcome data on the effectiveness of this approach are inconsistent. (rti.org)
  • Circulation
  • Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study," Circulation , vol. 2, no. 6, pp. 621-628, 2009. (hindawi.com)
  • dietary
  • There is an intimate relationship between diet and dyslipidemia, and dietary manipulations may be used to understand the mechanisms of these abnormalities. (diabetesjournals.org)
  • The final section, Section 5, describes dietary and pharmacological treatments that are available for dyslipidemia and cardiovascular disease, including both lifestyle measures and use of lipid-lowering medications. (ahajournals.org)
  • The determinants of dyslipidemia identified in this study were less frequent consumption of foods in the 'mixed diet' dietary pattern, higher body mass index, and lower level of maternal education. (scielo.br)
  • Research into determinants of dyslipidemia in Brazilian preschoolers that includes dietary patterns as an explanatory variable has not been conducted yet. (scielo.br)
  • Thus, the aim of the present study was to investigate the determinants of dyslipidemia in preschoolers by including dietary patterns, since they can predict disease risk better than single foods or nutrients. (scielo.br)
  • Genetic
  • citation needed] Physicians and basic researchers classify dyslipidemias in two distinct ways: Presentation in the body (including the specific type of lipid that is increased) Underlying cause for the condition (genetic, or secondary to another condition). (wikipedia.org)
  • risk
  • This article provides a framework for diagnosing and managing dyslipidaemia, with the aim of reducing patients' CVD risk. (bmj.com)
  • The third section focuses on dyslipidemia in specific groups of high-risk patients, including those with diabetes mellitus, renal disease, and atherosclerosis, children, the elderly, and women. (ahajournals.org)
  • diabetes
  • The most common conditions that were felt to be contributing to dyslipidemia were excessive alcohol intake (10 percent) and uncontrolled diabetes mellitus (8 percent). (uptodate.com)
  • patients
  • Dyslipidemia is a leading cause of cardiovascular morbidity and mortality and most patients with this condition fail to achieve adequate control of their serum lipid levels with monotherapy. (springer.com)
  • However, recent US and European guideline recommendations, based on randomized, controlled trials, fail to discuss combination therapy options for patients with dyslipidemia. (springer.com)
  • Eighty-one percent of all patients had dyslipidemia (DL) and a majority of the patients with abdominal measures below the recommended cut-off levels had DL. (diva-portal.org)